GLPG Competitors & Alternatives
Compare Galapagos NV ADR with similar stocks in the same industry
Biotechnology
GLPG
Main Stock$27.73
Tradestie Score
59
Market Cap
$2.31B
P/E Ratio
5.1
Revenue Growth
10.9%
Analyst Upside
+3.0%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MESO
Mesoblast Limited American Depositary Shares
|
$16.22
|
$2.08B | - | 60 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.82
|
$2.02B | 54.1 | 57 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.02
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$37.46
|
$1.97B | - | 60 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.88
|
$1.92B | - | 63 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$103.79
|
$1.92B | - | 58 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$71.21
|
$1.90B | 458.4 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$41.50
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.49
|
$1.81B | - | 62 | Compare |
|
MPLT
MPLT
|
$36.57
|
$1.78B | - | 63 | Compare |
More GLPG Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry